Medical Science Liaison

Responsibilities

• Identify and develop relationships with medical/scientific Thought Leaders, academic centers, and researchers
• Act as a liaison to align mutual interests and facilitate clinical research with investigational products
• Engage in scientific exchange regarding botulinum toxin use in movement disorders
• Communicate medical/scientific insights and trends to stakeholders
• Capture and document strategic insights from the field
• Provide scientific, clinical, and educational support for internal and external customers
• Support interactions with investigators for ongoing and planned clinical trials
• Represent the company at medical congresses, advisory boards, and roundtable discussions
• Ensure compliance with corporate policies and U.S. healthcare laws

Requirements

• PhD, MD, PharmD, DO or other recognized doctorate level education
• Minimum of 3 years MSL experience (5 years preferred)
• Minimum of 5 years post professional degree, practice, or relevant transferable experience
• Ability to travel > 50% including overnight and weekend travel
• Valid U.S. driver's license

Preferred Qualifications

• Expertise in neuromodulators (botulinum toxin/neurotoxins/movement disorders)
• Knowledge of market dynamics within Movement disorders
• Experience in Neurology and Physiatry
• Working knowledge of drug development, regulatory approval processes, and clinical trial methodologies
• Knowledge of PhRMA and OIG regulatory guidelines
• Proficiency in CRM software

Benefits

• $175,000-$190,000 annual base salary and annual performance bonus
• Flexible PTO, holidays, and parental leave
• Generous healthcare benefits and HSA match
• 401k match
• Employer paid life and disability insurance
• Pet insurance and wellness discounts

About the Company

Revance is a global company developing, producing, and distributing industry-leading, differentiated products across aesthetics, skincare, and therapeutics. The company is advancing treatments for movement disorders with DAXXIFY® (daxibotulinumtoxinA-lanm), the first and only peptide-formulated botulinum toxin.